CLINICAL_TRIALS
research
· 2026-02-17
Clinical Trial Update: Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI [Phase 2]
Summary
A Phase 2 clinical trial is evaluating cannabidiol as a treatment for post-traumatic stress disorder with comorbid traumatic brain injury; recruitment is ongoin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Post Traumatic Stress Disorder, Traumatic Brain Injury | Phase 2 | Status: RECRUITING